Calibration of the 1-MHz Sonitron ultrasound system.
Successful drug and gene delivery across cellular membranes can lead to improved therapeutic outcomes. Recent studies have suggested that sonoporation may enhance drug and gene delivery across cellular membranes. The enhancement may be a result of transient permeation of the membrane from cavitation or microstreaming effects of microbubbles exposed to ultrasound. Given limited acoustic pressure calibration and beam profile characterization of the Sonitron ultrasound systems in cellular bioeffects studies previously published, the objective of this work was to calibrate the acoustic output and explore the potential for standing waves in a cell-well plate. In this study, three 1-MHz transducers driven by Sonitron ultrasound systems, which have been used in a number of sonoporation studies, were calibrated. Transducers with 10-mm, 6-mm and 20-mm-diameter apertures (Sonitron 1000 and 2000, Rich-Mar, Inola, OK, USA) were calibrated using polyvinylidene fluoride (PVDF) needle hydrophones. Axial and transverse beam profiles were obtained, and the pressures were measured as a function of Sonitron intensity dial setting and duty cycle. The acoustic intensity was calculated and compared with the Sonitron intensity dial setting for duty cycles from 10-100%. Standing waves caused by reflections from the hydrophone holder were detected for each transducer. This observation may also have implications for in vitro sonoporation studies. Acoustic field characterization is an important first step in understanding the mechanisms of sonoporation and drug delivery across biomembranes.
Kopechek
Jonathan A
JA
Department of Biomedical Engineering, Colleges of Engineering and Medicine, University of Cincinnati, Cincinnati, OH 45267-0586, USA. kopechja@uc.edu
Kim
Hyunggun
H
McPherson
David D
DD
Holland
Christy K
CK
D002138:Calibration; D013010:Sonication / Q000295:instrumentation* / Q000592:standards*; D014159:Transducers / Q000592:standards; D014465:Ultrasonics / Q000379:methods*
Adv Drug Deliv Rev. 2005 Apr 5;57(5):733-53
15757758
Hum Cell. 2004 Mar;17(1):7-15
15369132
J Drug Target. 2007 Feb;15(2):109-14
17365281
Ultrasound Med Biol. 2009 Oct;35(10):1756-60
19647924
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1193-208
18474406
J Control Release. 2006 May 15;112(2):149-55
16556469
J Surg Res. 2005 Apr;124(2):312-7
15820263
Invest Ophthalmol Vis Sci. 2006 Feb;47(2):558-64
16431951
Cell Biol Int. 2005 Nov;29(11):976-9
16271302
Ultrasound Med Biol. 2009 Nov;35(11):1845-53
19699025
Exp Eye Res. 2007 Dec;85(6):741-8
17889849
Biochim Biophys Acta. 2004 Oct 11;1665(1-2):134-41
15471579
Cancer Lett. 2001 Nov 8;173(1):31-5
11578806
J Control Release. 2005 May 5;104(1):213-22
15866347
Biochem Biophys Res Commun. 2005 Oct 14;336(1):118-27
16125678
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1117-36
18486270
J Control Release. 2010 Jan 25;141(2):193-8
19804805
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1209-17
18486271
Ultrasound Med Biol. 1985 Nov-Dec;11(6):803-17
3913079
J Gene Med. 2005 Nov;7(11):1468-74
15991257
Biochem Biophys Res Commun. 2007 Aug 10;359(4):860-5
17568561
Thromb Res. 2007;119(6):777-84
16887172
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1177-92
18474407
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1167-76
18479776